National Institute of Allergy and Infectious Diseases Investor

National Institute of Allergy and Infectious Diseases (NIAID) conducts fundamental and applied research to gain a comprehensive understanding of infectious, immunological, and allergic diseases, as well as to develop new techniques for their treatment, prevention, and eventual eradication. Over six decades, NIAID research has resulted in the development of novel treatments, vaccines, and diagnostic methods, as well as other breakthroughs that have significantly improved the quality of life for millions of people worldwide, including in the United States.

Number Of Exists: 4
Technology: Clinical Decision Support Systems (CDSS)
Industry: Clinical AI
Founded Date: 1887-01-01
Investor Type: Donors
Employee Number: 1.5K
Headquarters: Bethesda,Maryland,United States,North America
Funding Status: private